ILGEN
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
841 E Fayette St, Syracuse, New York, 13...Phone Number
(917) 891-4943Website
www.ilgenbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About ILGEN
ILGEN Inc. is a biopharmaceutical company focused on developing novel proprietary biotechnology, including a first-in-class, naturally occurring LAG3 checkpoint inhibitor. Their innovative technology enables the efficient generation of high-affinity fully human antibodies for therapeutic and diagnostic applications, targeting various conditions such as cancer, infections, and autoimmune diseases. ILGEN's approach significantly reduces the turnaround time for antibody development, allowing for functionally validated antibodies to be produced in as little as six months. The company aims to provide advanced treatments, including a fully human fusion protein for erectile dysfunction, leveraging their patented technology.Explore more
Popular SearchesILGEN IncIlgenSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ILGEN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ILGEN is spiking on competitors!
ILGEN, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if ILGEN has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ILGEN
Click to see if ILGEN had a recent Job posting/layoffs
Product Launch: Get notified when ILGEN launches new products
Funding: Get notified immidiatlly once ILGEN has new funding data
Earning: See what the market has to say on ILGEN recently announced quarterly report
Recommended Actions
Find VP level buyers at ILGEN
Find 3 more new buyers
Compare Similar Companies to ILGEN
Compare insights from companies similar to ILGEN, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
ILGEN
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
ILGEN is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
ILGEN is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about ILGEN.
ILGEN Tech Stack
A closer look at the technologies used by ILGEN
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ILGEN
Sign Up For FreeTo access detailed company insights
ILGEN Inc. is a biopharmaceutical company focused on developing novel proprietary biotechnology, including a first-in-class, naturally occurring LAG3 checkpoint inhibitor. Their innovative technology enables the efficient generation of high-affinity fully human antibodies for therapeutic and diagnostic applications, targeting various conditions suc... Read More
